Clinical trial

A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD

NCT02276222

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-10-01

PhasePHASE3

Study timeline

Study start (unknown)2014-10-01Date precision: month

Registry last updated2018-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)unresolved

Interventions

SUN-101 50 mcg BID eFlow (CS) nebulizerDRUG

Spiriva® 18 mcg QD HandihalerDRUG

Sponsors & collaborators

Sunovion Respiratory Development Inc.lead sponsor

Mapped research locations

St LouisMissouri, United States3 MiamiFlorida, United States3 TampaFlorida, United States2 MinneapolisMinnesota, United States2 MoscowRussia2 Saint PetersburgRussia2 GreenvilleSouth Carolina, United States2 SpartanburgSouth Carolina, United States2 MedfordOregon, United States2 NovosibirskRussia2 HoustonTexas, United States1 Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02276222 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.